Web Analytics
Braskem SA (BAK) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives | Deepscope News
MARKET

Select Market Data Region

 March 31, 2026 08:01 AM  finance.yahoo.com Positive

Braskem SA (BAK) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic Initiatives

Image

This article first appeared on GuruFocus.

Recurring Consolidated EBITDA (Q4 2025): $109 million. Recurring Consolidated EBITDA (Full Year 2025): $557 million, a 49% decrease versus 2024. Operating Cash Flow (Q4 2025): $13 million generated. Operating Cash Consumption (Full Year 2025): $246 million. Corporate Cash (End of Q4 2025): $2.1 billion, including a $1 billion standby facility. Corporate Leverage (End of 2025): 14.74 times. Brazil Segment Recurring EBITDA (2025): $698 million, 22% lower than 2024. United States and Europe Segment Recurring EBITDA (2025): Negative $52 million. Mexico Segment Recurring EBITDA (Q4 2025): $2 million. Adjusted Net Debt (End of 2025): $7.5 billion, excluding Braskem Idesa. Provision for Alagoas Event (End of 2025): BRL3.5 billion remaining. Total Cash Consumption (2025): Approximately BRL7.3 billion, including Alagoas disbursement.

Warning! GuruFocus has detected 7 Warning Signs with BAK. Is BAK fairly valued? Test your thesis with our free DCF calculator.

Release Date: March 27, 2026

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

Positive Points

Braskem SA (NYSE:BAK) recorded a recurring consolidated EBITDA of $109 million in Q4 2025 and $557 million for the full year, despite challenging market conditions. The company maintained a strong safety record with a global accident frequency rate of 0.80 events per million hours worked, the second lowest since 2002. Braskem SA (NYSE:BAK) has a strategic plan to reduce dependency on naphtha by increasing the use of gas and ethanol, aiming for a 60% naphtha and 40% gas/ethanol mix by 2030. The company has implemented over 700 initiatives to preserve liquidity and reinforce competitiveness, resulting in $500 million in EBITDA and $600 million in cash generation for 2025. Braskem SA (NYSE:BAK) has a robust cash position with $2.1 billion in corporate cash, including a $1 billion standby facility maturing in December 2026.

Negative Points

The petrochemical industry faced a prolonged downcycle in 2025, with international petrochemical spreads below historical averages, impacting Braskem SA (NYSE:BAK)'s profitability. Utilization rates in Brazil were 4 percentage points lower than the previous year due to production adjustments, and Mexico saw reduced production due to maintenance shutdowns. Recurring EBITDA for the Brazil segment was $698 million, 22% lower than in 2024, due to lower sales volumes and average spreads. Braskem SA (NYSE:BAK) faced a significant operating cash consumption of BRL1.4 billion for the year, driven by lower EBITDA and increased working capital consumption. The company's corporate leverage was high at approximately 14.74 times, reflecting financial strain amid the challenging industry conditions.

Story Continues

Q & A Highlights

Q: Considering the current context, could you provide a view of how the global industry has behaved? Have you seen reduction of relevant capacity or events of force majeure impacting the business? How are petrochemical spreads responding as a result of the conflict? A: Roberto Prisco Paraiso Ramos, CEO: The Asian petrochemical powers have lower naphtha inventories than we do, and we started the war with a larger supply of feedstock. We import naphtha mainly from the US, which is not impacted by conflicts, although prices have increased. Our strategy is to reduce dependency on naphtha, aiming for a 60% naphtha and 40% ethanol and gas mix by 2030. The conflict's duration will significantly impact petrochemical supply and logistics chains.

Q: What would be the effect of the war on the EBITDA of the company? Could we expect an EBITDA about $1 billion? A: Rosana Avolio, Investor Relations Director: The company does not provide formal guidance, but historical consolidated EBITDA between 2014 and 2025 was about $2.54 billion. Considering current market references and external consultancy expectations, we could reach historical levels, but it's too early to predict a future scenario.

Q: With the default of the bond interest rates and the lower ratings to D and possible reorganization via Chapter 11, what's the real likelihood of this scenario to materialize for Braskem Idesa? A: Felipe Montoro Jens, CFO: We are engaged in reorganizing Braskem Idesa's capital structure with legal and financial advisers. It's a priority, and we will share material information as soon as it's available. Speculating on the likelihood of Chapter 11 is not possible at this stage.

Q: What was the result of the meeting regarding the antidumping process of polyethylene in Brazil? Will new protections be implemented? A: Roberto Prisco Paraiso Ramos, CEO: Gecex opted not to consider the detailed study recommending a $700 per ton antidumping norm for ethylene from the US, maintaining provisional protection. We will appeal this decision as we believe the antidumping case is strong and well demonstrated.

Q: How is the company going to finance the Transforma Rio project and other strategic investments considering high leverage and cash burn? A: Roberto Prisco Paraiso Ramos, CEO: The restructuring of the company's capital structure includes necessary resources for the Transforma Rio project. This project is essential for transforming Braskem, and financing takes into account the integration of feedstock changes and sustainability improvements.

For the complete transcript of the earnings call, please refer to the full earnings call transcript.

View Comments

Read original source